| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $332.3M | +185.7% |
| R&D Expense | $46.2M | -46.3% |
| SG&A Expense | $163.1M | +14.4% |
| Operating Income | $54.4M | +135.0% |
| Income Tax | $0 | — |
| Net Income | -$51.7M | +75.3% |
| EPS (Basic) | -$0.28 | +86.2% |
| EPS (Diluted) | -$0.28 | +86.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.8M | +76.0% |
| Accounts Receivable | $80.1M | +65.3% |
| Inventory | $94.5M | +44.0% |
| Current Assets | $338.0M | +68.1% |
| Total Assets | $343.8M | +67.1% |
| Current Liabilities | $246.2M | +57.6% |
| Total Liabilities | $732.5M | +10.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | +82.5% |
| Capital Expenditures | $317K | — |
| Investing Cash Flow | -$317K | -100.7% |
| Financing Cash Flow | $86.5M | +71.4% |
| Free Cash Flow | -$24.0M | +82.3% |
| Stockholders' Equity |
| -$388.7M |
| +14.6% |